Clinical Trials Directory

Trials / Completed

CompletedNCT05920954

Urgent (<24 Hours) Versus Early (24 to 48 Hours) ERCP for Patients With Mild and Moderate Acute Cholangitis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
304 (actual)
Sponsor
Asian Institute of Gastroenterology, India · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

Acute Cholangitis is an emergency associated with significant morbidity and mortality which require prompt recognition and treatment. The decompression of biliary tree along with antibiotics are mainstay of therapy. Randomized comparative studies showed that ERCP achieves biliary decompression with markedly less morbidity and mortality compared with surgery, regardless of clinical drainage. Percutaneous trans hepatic drainage (PTBD) can be alternative to endoscopic drainage in selected group especially advanced hilar strictures and patients who are unfit for endoscopic procedure. Recent ASGE guidelines suggested the performance of ERCP within 48 hours for patients with acute cholangitis; however it is conditional recommendation with very low quality of evidence. Till date, no randomized trial has compared urgent ERCP versus early ERCP for acute cholangitis.

Conditions

Interventions

TypeNameDescription
PROCEDUREERCPRepeat ERCP

Timeline

Start date
2023-06-30
Primary completion
2024-06-10
Completion
2024-07-10
First posted
2023-06-27
Last updated
2025-10-02

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT05920954. Inclusion in this directory is not an endorsement.

Urgent (<24 Hours) Versus Early (24 to 48 Hours) ERCP for Patients With Mild and Moderate Acute Cholangitis (NCT05920954) · Clinical Trials Directory